SCHEMBL19638068

SCHEMBL19638068

Br[Zn]Br.C[CH]c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.39
ALDH1A1 P00352 4/20 0.39
TSHR P16473 2/20 0.39
MAOB P27338 2/20 0.39
CYP2A6 P11509 1/20 0.39
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CHAT P28329 2/20 0.36
TRPA1 O75762 2/20 0.34
RELA Q04206 1/20 0.34
GLA P06280 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NFE2L2 Q16236 1/20 0.33
CYP19A1 P11511 1/20 0.33
MAOA P21397 1/20 0.33
ALOX5 P09917 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL886 0.88
SCHEMBL724748 0.72 ALDH1A1 (0.50) ALDH1A1LMNAL3MBTL1TDP1MAPK1
SCHEMBL1302 0.68 ALDH1A1 (0.53) ALDH1A1TSHRMAOBCYP2A6LMNA
SCHEMBL2186055 0.67 TP53 (0.40) ALDH1A1MAOBTDP1NFE2L2CYP19A1
SCHEMBL29111027 0.67 ALDH1A1 (0.53) AKR1C3ALDH1A1TSHRMAOBCYP2A6
SCHEMBL9368926 0.67 CALM1 (0.57) MAOBLMNAL3MBTL1
SCHEMBL723501 0.67 LTA4H (0.57) ALDH1A1TSHRLMNAL3MBTL1TRPA1
SCHEMBL1005178 0.67 MAOA (0.44) ALDH1A1MAOAALOX5
SCHEMBL22711559 0.65 ALDH1A1 (0.50) ALDH1A1TSHRMAOBCYP2A6LMNA
SCHEMBL29124096 0.65 ALDH1A1 (0.50) ALDH1A1TSHRMAOBCYP2A6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115626923-B KRAS G12C inhibitors and methods of use thereof 美国安进公司 2024-08-02 CN disclosed
CN-112279808-B Cystic fibrosis transmembrane conductance regulator modulators 弗特克斯药品有限公司 2024-03-08 CN disclosed
CN-112250627-B Cystic fibrosis transmembrane conductance regulator modulators 弗特克斯药品有限公司 2024-02-02 CN disclosed
CN-116621833-A KRAS G12C inhibitors and methods of use thereof 美国安进公司 2023-08-22 CN disclosed
CN-116606261-A KRAS G12C inhibitors and methods of use thereof 美国安进公司 2023-08-18 CN disclosed
CN-110003217-B Compositions useful for treating disorders associated with KIT 缆图药品公司 2022-10-18 CN disclosed
CN-112279808-A Cystic fibrosis transmembrane transduction modulator modulators 弗特克斯药品有限公司 2021-01-29 CN disclosed
CN-112250627-A Cystic fibrosis transmembrane transduction modulator modulators 弗特克斯药品有限公司 2021-01-22 CN disclosed
CN-107690281-B Cystic fibrosis transmembrane transduction modulator modulators 弗特克斯药品有限公司 2020-11-17 CN disclosed
US-10577460-B2 Method for producing polyester NIPPON SODA CO., LTD. (JP) 2020-03-03 US disclosed
CN-110366550-A Benzoisothiazole, isothiazolo [3,4-b ] pyridine, quinazoline, phthalazine, pyrido [2,3-d ] pyridazine and pyrido [2,3-d ] pyrimidine derivatives as KRAS G12C inhibitors for the treatment of lung, pancreatic or colorectal cancer 美国安进公司 2019-10-22 CN disclosed
CN-110003217-A It can be used for treating the composition of illness relevant to KIT 蓝图药品公司 2019-07-12 CN disclosed
CN-107108871-B The manufacturing method of polyester 日本曹达株式会社 2019-04-30 CN disclosed
CN-105658652-B Compositions useful for treating disorders associated with KIT 蓝图药品公司 2019-04-12 CN disclosed
CN-107690281-A Cystic fibrosis transmembrane transduction modulator modulators 弗特克斯药品有限公司 2018-02-13 CN disclosed
EP-3248998-A1 METHOD FOR PRODUCING POLYESTER Nippon Soda Co., Ltd. (JP) 2017-11-29 EP disclosed
CN-107108871-A The manufacture method of polyester 日本曹达株式会社 2017-08-29 CN disclosed
CN-106999479-A It can be used as the heteroaryl compound of SUMO activating enzyme inhibitors 米伦纽姆医药公司 2017-08-01 CN disclosed
CN-101970437-B Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals SANOFI AVENTIS 2013-04-03 CN disclosed